Cargando…

Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology

BACKGROUND AND AIMS: The recently developed histological scoring system for non-alcoholic fatty liver disease (NAFLD) by the NASH Clinical Research Network (NASH-CRN) has been widely used in clinical settings, but is increasingly employed in preclinical research as well. However, it has not been sys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Wen, Menke, Aswin L., Driessen, Ann, Koek, Ger H., Lindeman, Jan H., Stoop, Reinout, Havekes, Louis M., Kleemann, Robert, van den Hoek, Anita M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275274/ https://www.ncbi.nlm.nih.gov/pubmed/25535951 http://dx.doi.org/10.1371/journal.pone.0115922

Ejemplares similares

A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology
por: van den Hoek, Anita M., et al.
Publicado: (2020)

Caloric Restriction Combined with Immobilization as Translational Model for Sarcopenia Expressing Key-Pathways of Human Pathology
por: de Jong, Jelle C.B.C, et al.
Publicado: (2023)

Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice
por: Morrison, Martine C., et al.
Publicado: (2018)

Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease
por: Miao, Zong, et al.
Publicado: (2021)

The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis
por: Mulder, Petra, et al.
Publicado: (2017)

Risk of severe illness of COVID‐19 patients with NAFLD and increased NAFLD fibrosis scores
por: Yao, Renling, et al.
Publicado: (2021)

Improved pathology reporting in NAFLD/NASH for clinical trials
por: Langford, Caitlin Rose, et al.
Publicado: (2022)

Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review
por: Lee, Jenny, et al.
Publicado: (2021)

Spatial and Temporal Gene Function Studies in Rodents: Towards Gene-Based Therapies for Autism Spectrum Disorder
por: Riemersma, Iris W., et al.
Publicado: (2021)

Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men
por: van den Hoek, Anita M., et al.
Publicado: (2021)

Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score
por: Tapper, Elliot B., et al.
Publicado: (2016)

Clusterin Plasma Concentrations Are Decreased in Sepsis and Inversely Correlated with Established Markers of Inflammation
por: Yagmur, Eray, et al.
Publicado: (2022)

Establishing Institutional Scores With the Rigor and Transparency Index: Large-scale Analysis of Scientific Reporting Quality
por: Menke, Joe, et al.
Publicado: (2022)

Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort
por: Wang, Jun, et al.
Publicado: (2021)

Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models
por: Esquejo, Ryan M., et al.
Publicado: (2018)

Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD
por: Drummer, Charles I. V., et al.
Publicado: (2021)

The Effect of Bariatric Surgery on Liver Histology
por: De Ridder, Rogier, et al.
Publicado: (2007)

Rodent Brain Pathology, Audiogenic Epilepsy
por: Fedotova, Irina B., et al.
Publicado: (2021)

Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness
por: Liebig, Stephanie, et al.
Publicado: (2019)

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023)

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
por: Cichoż-Lach, Halina, et al.
Publicado: (2012)

Establishment of Metabolism and Transport Pathways in the Rodent and Human Fetal Liver
por: Moscovitz, Jamie E., et al.
Publicado: (2013)

Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models
por: Wang, Qilong, et al.
Publicado: (2019)

Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores
por: Noureddin, Mazen, et al.
Publicado: (2023)

Normal and abnormal development of the aortic valve and ascending aortic wall: a comprehensive overview of the embryology and pathology of the bicuspid aortic valve
por: Grewal, Nimrat, et al.
Publicado: (2022)

The role of non-invasive scores in determining the liver fibrosis in NAFLD and psoriatic patients
por: Neagoe, Carmen-Daniela, et al.
Publicado: (2020)

NAFLD polygenic risk score and risk of hepatocellular carcinoma in an East Asian population
por: Thomas, Claire E., et al.
Publicado: (2022)

Clinical Pathology and Sample Collection in the Laboratory Rodent
por: McClure, Diane E.
Publicado: (1999)

Heat-Inactivated Akkermansia muciniphila Improves Gut Permeability but Does Not Prevent Development of Non-Alcoholic Steatohepatitis in Diet-Induced Obese Ldlr−/−.Leiden Mice
por: Morrison, Martine C., et al.
Publicado: (2022)

Intracerebroventricular Administration of Neuropeptide Y Induces Hepatic Insulin Resistance via Sympathetic Innervation
por: van den Hoek, Anita M., et al.
Publicado: (2008)

72 Establishing a histologically defined NAFLD cohort in the Million Veteran Program for further genetic analyses
por: Mukherjee, Samiran, et al.
Publicado: (2023)

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
por: Heyens, Leen J. M., et al.
Publicado: (2021)

NAFLD in the Elderly
por: Alqahtani, Saleh A, et al.
Publicado: (2021)

Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies
por: Morrison, Martine C., et al.
Publicado: (2015)

The Basolateral Amygdala Is Essential for Rapid Escape: A Human and Rodent Study
por: Terburg, David, et al.
Publicado: (2018)

Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)
por: Yan, Ran, et al.
Publicado: (2022)

Plasma ApoE elevations are associated with NAFLD: The PREVEND Study
por: van den Berg, Eline H., et al.
Publicado: (2019)

Mechanism-Based Biomarker Prediction for Low-Grade Inflammation in Liver and Adipose Tissue
por: van Bilsen, Jolanda H. M., et al.
Publicado: (2021)

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2010)

Simple Scores of Fibrosis and Mortality in Patients with NAFLD: A Systematic Review with Meta-Analysis
por: Salomone, Federico, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m7vimgempgdkmlsvuob2bsqbpr